Recently, Fumihiko Urano, MD, PhD joined “It Happened to Me” podcast hosts Cathy Gildenhorn and Beth Glassman to discuss Wolfram syndrome and his ongoing research. Dr. Urano is the director of the Wolfram Syndrome International Registry & Clinical Study and the doctor of Cathy, who has a variant of the disease. Wolfram syndrome is an […]
On September 11, 2023, Fumihiko Urano, MD, PhD and Sina Jasim, MD, MPH, were featured on the AACE’s podcast titled “Episode 41: AACE Clinical Case Report on Wolfram Syndrome.” As the editor in chief of AACE Clinical Case Reports, Dr. Jasim welcomes Wolfram syndrome expert Dr. Urano, to discuss his recent case report, published by […]
On March 30, Cris Brown, BA and Fumihiko Urano, MD, PhD of Urano Lab, alongside colleagues from Belgique, Belgium and Italy, had their article titled “GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models,” published in Diabetologia. Wolfram syndrome is a rare autosomal recessive disorder that commonly manifests itself in the form […]
In April, Fumihiko Urano, MD, PhD was featured in the documentary “Colorado Voices: Ellie White,” to raise awareness of the rare genetic disorder, Wolfram syndrome. The short documentary was published by Rocky Mountain PBS and tells the story of Colorado college student Ellie White, who lives with the disorder. Although the disorder is very rare […]
In January, Fumihiko Urano, MD, PhD and collaborator, Shuntaro Morikawa had their research review titled “The Role of ER Stress in Diabetes: Exploring Pathological Mechanisms Using Wolfram Syndrome,” published in the “International Journal of Molecular Sciences.” Endoplasmic reticulum (ER) is an important cytosolic organelle that contributes to the folding and processing of new secretory proteins, […]
The Snow Foundation, the Ellie White Foundation, and the Unravel Wolfram Syndrome have donated funds to the research lab of Fumihiko Urano, MD, PhD. The research team will use the funds to test the efficacy of a Sigma 1 receptor agonist, pridopidine, developed by Prilenia in pre-clinical models of Wolfram syndrome. Successful completion of this […]
On September 22, Jeffrey R. Millman, PhD and Fumihiko Urano, MD, PhD, along with colleagues, had their research titled, “Multidimensional analysis and therapeutic development using patient iPSC–derived disease models of Wolfram syndrome,” published in “JCI Insight.” “Wolfram syndrome is a rare genetic disorder largely caused by pathogenic variants in the WFS1 gene and manifested by diabetes mellitus, […]
On April 12, Fumihiko Urano, MD, PhD and colleagues had their research titled, “Plasma Neurofilament Light Chain Levels Are Elevated in Children and Young Adults With Wolfram Syndrome,” published in “Frontiers in Neuroscience.” “Wolfram syndrome is a rare disease caused by pathogenic variants in the WFS1 gene with progressive neurodegeneration. As an easily accessible biomarker […]